Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 2
1962 1
1963 4
1964 1
1965 1
1966 1
1974 1
1978 2
1979 4
1982 5
1983 2
1984 2
1985 4
1986 5
1987 9
1988 14
1989 9
1990 12
1991 17
1992 14
1993 10
1994 14
1995 26
1996 28
1997 40
1998 46
1999 44
2000 71
2001 47
2002 59
2003 70
2004 98
2005 104
2006 109
2007 111
2008 144
2009 176
2010 166
2011 191
2012 219
2013 221
2014 264
2015 288
2016 262
2017 271
2018 282
2019 332
2020 395
2021 454
2022 273
Text availability
Article attribute
Article type
Publication date

Search Results

4,418 results
Results by year
Filters applied: . Clear all
Page 1
Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants.
Li T, Xue W, Zheng Q, Song S, Yang C, Xiong H, Zhang S, Hong M, Zhang Y, Yu H, Zhang Y, Sun H, Huang Y, Deng T, Chi X, Li J, Wang S, Zhou L, Chen T, Wang Y, Cheng T, Zhang T, Yuan Q, Zhao Q, Zhang J, McLellan JS, Zhou ZH, Zhang Z, Li S, Gu Y, Xia N. Li T, et al. Among authors: hong m. Nat Commun. 2021 Sep 27;12(1):5652. doi: 10.1038/s41467-021-25997-3. Nat Commun. 2021. PMID: 34580306 Free PMC article.
Kinectin 1 promotes the growth of triple-negative breast cancer via directly co-activating NF-kappaB/p65 and enhancing its transcriptional activity.
Gao L, Chen S, Hong M, Zhou W, Wang B, Qiu J, Xia J, Zhao P, Fu L, Wang J, Dai Y, Xie N, Yang Q, Huang HD, Gao X, Zou C. Gao L, et al. Among authors: hong m. Signal Transduct Target Ther. 2021 Jul 5;6(1):250. doi: 10.1038/s41392-021-00652-x. Signal Transduct Target Ther. 2021. PMID: 34219129 Free PMC article.
Solid-state NMR spectroscopy.
Reif B, Ashbrook SE, Emsley L, Hong M. Reif B, et al. Among authors: hong m. Nat Rev Methods Primers. 2021;1:2. doi: 10.1038/s43586-020-00002-1. Epub 2021 Jan 14. Nat Rev Methods Primers. 2021. PMID: 34368784 Free PMC article.
Optical coherence tomography in coronary atherosclerosis assessment and intervention.
Araki M, Park SJ, Dauerman HL, Uemura S, Kim JS, Di Mario C, Johnson TW, Guagliumi G, Kastrati A, Joner M, Holm NR, Alfonso F, Wijns W, Adriaenssens T, Nef H, Rioufol G, Amabile N, Souteyrand G, Meneveau N, Gerbaud E, Opolski MP, Gonzalo N, Tearney GJ, Bouma B, Aguirre AD, Mintz GS, Stone GW, Bourantas CV, Räber L, Gili S, Mizuno K, Kimura S, Shinke T, Hong MK, Jang Y, Cho JM, Yan BP, Porto I, Niccoli G, Montone RA, Thondapu V, Papafaklis MI, Michalis LK, Reynolds H, Saw J, Libby P, Weisz G, Iannaccone M, Gori T, Toutouzas K, Yonetsu T, Minami Y, Takano M, Raffel OC, Kurihara O, Soeda T, Sugiyama T, Kim HO, Lee T, Higuma T, Nakajima A, Yamamoto E, Bryniarski KL, Di Vito L, Vergallo R, Fracassi F, Russo M, Seegers LM, McNulty I, Park S, Feldman M, Escaned J, Prati F, Arbustini E, Pinto FJ, Waksman R, Garcia-Garcia HM, Maehara A, Ali Z, Finn AV, Virmani R, Kini AS, Daemen J, Kume T, Hibi K, Tanaka A, Akasaka T, Kubo T, Yasuda S, Croce K, Granada JF, Lerman A, Prasad A, Regar E, Saito Y, Sankardas MA, Subban V, Weissman NJ, Chen Y, Yu B, Nicholls SJ, Barlis P, West NEJ, Arbab-Zadeh A, Ye JC, Dijkstra J, Lee H, Narula J, Crea F, Nakamura S, Kakuta T, Fujimoto J, Fuster V, Jang IK. Araki M, et al. Among authors: hong mk. Nat Rev Cardiol. 2022 Apr 21. doi: 10.1038/s41569-022-00687-9. Online ahead of print. Nat Rev Cardiol. 2022. PMID: 35449407 Review.
4,418 results